Navigation Links
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
Date:3/11/2009

x receivable 556 -- -- Deferred tax assets 1,857 781 114 Total assets 973,475 952,918 139,672 Liabilities Current liabilities Accounts payable 1,693 1,939 284 Deferred grant income 374 374 55 Accrued expenses and other payables 22,626 25,273 3,705 Income tax payable -- 1,256 184 Other current liabilities 67 57 8 Total current liabilities 24,760 28,899 4,236 Deferred grant income 3,526 3,152 462 Other liabilities 848 472 69 Total liabilities 29,134 32,523 4,767 Commitments and contingencies Minority interests 549 -- -- Shareholders' equity Share capital - ordinary shares US$0.0001 par value, 500,000,000 shares authorized, 152,099,155 and 150,575,955 shares issued and outstanding as of December 31, 2007 and 2008, respectively 122 121 18 Additional paid-in capital 917,527 908,377 133,144 Accumulated other comprehensive loss (48,338) (102,126) (14,970) Retained earnings 74,481 114,023 16,713 Total shareholders' equity 943,792 920,395 134,905 Total liabilities, minority interests and shareholders' equity 973,475 952,918 139,672 Reconciliation Tables of GAAP to Adjusted Non-GAAP Figures Three Months Ended
'/>"/>
SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
2. 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
3. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
4. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
5. 3SBio Inc. Announces Third Quarter 2008 Results
6. 3SBio Inc. Files for SFDA Approval of NuLeusin
7. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
8. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
9. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
10. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
11. 3SBio Inc. Announces Results of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...ciences, Inc.,(OTC Bulletin Board: DSCI), a provid...s increased its direct-sales staff significantly, ... favor in target markets. The,company, which had o...now,has nine, and will move to 21 by 2009. The inc...ch has been growing sales at an accelerating rate,...
...t 7:00 p.m. Eastern Time in Conjunction with ...e - REDWOOD CITY, Calif. and SUNNYVALE, Calif.,...tive,Surgical, Inc. (Nasdaq: ISRG ) today announc...c of "Advanced Techniques and Technologies in Robo...pair." The symposium will,feature Intuitive,s da V...
...tinue pre-adoption clinical evaluation of ...CJD now means that all the population is susceptib... Increased concerns over "second wave" of vCJD in ...r incubation times - P-Capt(R) prion reduction f... against potential transmission of the disease in ...
Other Biology Technology:Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 2Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 3Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 2Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 3Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 4Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 5ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 2ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 3ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 4ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 5
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 1WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 2WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 3Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 1Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 2Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 3Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 4AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 1AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 2
...ifficult to eliminate tumours effectively. Deciph...e immune system,s effect on tumour cells and thus ...mmune therapy. At the Institut Curie, INSERM and ...o demonstrate, for the first time in vivo and real... in order to fight it. , These "defenders" methodi...
...n examine single molecules in order to determine g...ore accurately examine single cancer cells, has be...rchers at UCLA,s California Nanosystems Institute...f Mathematical Sciences, and Veeco Instruments, a ...January issue of the journal Nanotechnology. , Pr...
... have discovered that the same ingredient used in ...d flaking on your head also can calm overexcited n... treatment for seizures. Results of the study can ...lepsy and other seizure disorders result when nerv...in. The brain’s “off?switches fail in part due to ...
Other Biology News:How T lymphocytes attack 2How T lymphocytes attack 3Anti-dandruff compound may help fight epilepsy 2
Corning Culture Flask, 25 cm2, Tc-Treated, Angled Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
LIC Duet™ T7•Tag® Ek Adaptor from Novagen
Corning Culture Flask, 75 cm2, Tc-Treated, Straight Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Novus Biologicals
Biology Products: